Evidence map›Paper›PMID 39155548›Full record

ReviewPharmacology research & perspectives2024

Hypothalamic cannabinoid signaling: Consequences for eating behavior.

Magen N Lord, Emily E Noble

Abstract readReview
In one paragraph

Review in Pharmacology research & perspectives, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Pharmacology and Regulation of Appetite and Food Intake.Pharmacology research & perspectives · 2025
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Magen N LordDepartment of Nutritional Sciences, University of Georgia, Athens, Georgia, USA.
Emily E NobleDepartment of Nutritional Sciences, University of Georgia, Athens, Georgia, USA.ORCID 0000-0002-7483-031X

Funding

Melanin-concentrating hormone and the neural regulation of feedingK01DK118000 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI NOBLE, EMILY ELIZABETH · 2019 to 2023
$769k
NIDDK NIH HHS K01 DK118000NIH HHS DK118000
6 · The paper itself

Abstract

In parallel to the legalization of cannabis for both medicinal and recreational purposes, cannabinoid use has steadily increased over the last decade in the United States. Cannabinoids, such as tetrahydrocannabinol and anandamide, bind to the central cannabinoid-1 (CB1) receptor to impact several physiological processes relevant for body weight regulation, including appetite and energy expenditure. The hypothalamus integrates peripheral signals related to energy balance, houses several nuclei that orchestrate eating, and expresses the CB1 receptor. Herein we review literature to date concerning cannabinergic action in the hypothalamus with a specific focus on eating behaviors. We highlight hypothalamic areas wherein researchers have focused their attention, including the lateral, arcuate, paraventricular, and ventromedial hypothalamic nuclei, and interactions with the hormone leptin. This review serves as a comprehensive analysis of what is known about cannabinoid signaling in the hypothalamus, highlights gaps in the literature, and suggests future directions.

Indexed as

CannabinoidsFeeding BehaviorHypothalamusReceptor, Cannabinoid, CB1Signal TransductionAnimalsEnergy MetabolismHumansLeptinCannabinoidsLeptinReceptor, Cannabinoid, CB1CB1 receptorendocannabinoidenergy balancefeedingfood intakehedonichomeostaticleptin

Identifiers

PMID39155548
PMCPMC11331011

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.